P. Subramanian

发表

Clinical Relevance of Multicolour Flow Cytometry in Plasma Cell Disorders

G. Chatterjee, S. Gujral, P. Subramanian, 2017, Indian Journal of Hematology and Blood Transfusion.

Atypical activation of signaling downstream of inactivated Bcr-Abl mediates chemoresistance in chronic myeloid leukemia

S. Dalal, Sanjay Gupta, P. Subramanian, 2021, Journal of Cell Communication and Signaling.

Eleven‐marker 10‐color flow cytometric assessment of measurable residual disease for T‐cell acute lymphoblastic leukemia using an approach of exclusion

G. Chatterjee, S. Gujral, P. Subramanian, 2020, Cytometry. Part B, Clinical cytometry.

Evaluation of cytogenetic response in CML patients with variant Philadelphia translocation

P. Subramanian, Dhanlaxmi Shetty, N. Patkar, 2021, Asia-Pacific journal of clinical oncology.

Outcomes and prognostic factors in adolescents and young adults with ALL treated with a modified BFM-90 protocol.

G. Chatterjee, P. Subramanian, P. Tembhare, 2021, Blood advances.

Immunogenetics of chronic lymphocytic leukemia

S. Gujral, P. Subramanian, P. Tembhare, 2017, Indian journal of pathology & microbiology.

Improved protocol for plasma microRNA extraction and comparison of commercial kits

G. Chatterjee, S. Gujral, P. Subramanian, 2021, Biochemia medica.

Sudden blast phase in pediatric chronic myeloid leukemia‐chronic phase with abnormal lymphoid blasts detected by flow cytometry at diagnosis: Can it be considered a warning sign?

G. Chatterjee, S. Gujral, P. Subramanian, 2020, Cytometry. Part B, Clinical cytometry.

Comprehensive immune cell profiling depicts an early immune response associated with severe coronavirus disease 2019 in cancer patients

S. Nair, Sudeep Gupta, V. Murthy, 2021, Immunology and cell biology.

Bortezomib and cyclophosphamide based chemo-mobilization in multiple myeloma

S. Kannan, S. Gujral, P. Subramanian, 2020, International Journal of Hematology.

Mutational landscape of Juvenile Myelomonocytic Leukemia (JMML)—A real‐world context

G. Chatterjee, S. Gujral, P. Subramanian, 2021, International journal of laboratory hematology.

Clinical characteristics, laboratory parameters and outcomes of COVID‐19 in cancer and non‐cancer patients from a tertiary Cancer Centre in India

S. Kannan, S. Nair, Sudeep Gupta, 2021, Cancer medicine.

N Gene Target Failure (NGTF) for detection of Omicron: a way out for the "stealth" too?

S. Nair, Sudeep Gupta, V. Murthy, 2022, medRxiv.

Clinical course of severe COVID19 treated with tocilizumab and antivirals post‐allogeneic stem cell transplant with extensive chronic GVHD

Ashutosh Kumar Singh, Sudeep Gupta, A. Joshi, 2021, Transplant infectious disease : an official journal of the Transplantation Society.

Bortezomib and Rituximab in de-novo adolescent/adult CD20-positive, Ph-negative Pre B-cell acute lymphoblastic leukemia.

S. Gujral, P. Subramanian, P. Tembhare, 2021, Blood advances.

BCR‐ABL1 kinase domain mutations: Methodology and clinical evaluation

D. Marin, J. Goldman, L. Foroni, 2012, American journal of hematology.

Mast cell differentiation of leukemic blasts in diverse myeloid neoplasms: A potential pre‐myelomastocytic leukemia condition

G. Chatterjee, S. Gujral, P. Subramanian, 2020, Cytometry. Part B, Clinical cytometry.

Expression levels and patterns of B‐cell maturation antigen in newly diagnosed and relapsed multiple myeloma patients from Indian subcontinent

G. Chatterjee, S. Gujral, P. Subramanian, 2022, Cytometry. Part B, Clinical cytometry.

Detecting hypodiploidy with endoreduplication and masked hypodiploidy in B‐cell acute lymphoblastic leukemia using multicolor flow cytometry

G. Chatterjee, S. Gujral, P. Subramanian, 2022, Cytometry. Part B, Clinical cytometry.

Outcomes in adolescent and young adult acute lymphoblastic leukaemia: a report from the Indian Acute Leukaemia Research Database (INwARD) of the Hematology Cancer Consortium (HCC)

B. George, V. Mathews, Ambily Nadaraj, 2021, British journal of haematology.

Role of cytogenetic abnormalities detected by fluorescence in situ hybridization as a prognostic marker: Pathogenesis & clinical course in patients with B-chronic lymphocytic leukaemia

P. Subramanian, M. Sengar, H. Jain, 2021, The Indian journal of medical research.

Flow cytometric evaluation of CD38 expression levels in the newly diagnosed T-cell acute lymphoblastic leukemia and the effect of chemotherapy on its expression in measurable residual disease, refractory disease and relapsed disease: an implication for anti-CD38 immunotherapy

G. Chatterjee, S. Gujral, P. Subramanian, 2020, Journal for immunotherapy of cancer.

Clinical impact of panel-based error-corrected next generation sequencing versus flow cytometry to detect measurable residual disease (MRD) in acute myeloid leukemia (AML)

G. Chatterjee, S. Gujral, P. Subramanian, 2021, Leukemia.

Post-induction Measurable Residual Disease Using Multicolor Flow Cytometry Is Strongly Predictive of Inferior Clinical Outcome in the Real-Life Management of Childhood T-Cell Acute Lymphoblastic Leukemia: A Study of 256 Patients

G. Chatterjee, S. Gujral, P. Subramanian, 2020, Frontiers in Oncology.

Clinical impact of measurable residual disease monitoring by ultradeep next generation sequencing in NPM1 mutated acute myeloid leukemia

S. Kannan, S. Gujral, P. Subramanian, 2018, Oncotarget.

Genomic Analysis of AZD1222 (ChAdOx1) Vaccine Breakthrough Infections in the City of Mumbai

R. Dikshit, P. Chaturvedi, S. Nair, 2022, International journal of clinical practice.

Clinicoepidemiological profiles, clinical practices, and the impact of holistic care interventions on outcomes of pediatric hematolymphoid malignancies - A 7-year audit of the pediatric hematolymphoid disease management group at Tata Memorial Hospital.

S. Gujral, P. Subramanian, P. Tembhare, 2017, Indian journal of cancer.

A novel and easy FxCycle™ violet based flow cytometric method for simultaneous assessment of DNA ploidy and six‐color immunophenotyping

S. Gujral, P. Subramanian, P. Tembhare, 2016, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

Pediatric cancer‐associated thrombosis: Analysis from a tertiary care cancer center in India

S. Gujral, P. Subramanian, C. Dhamne, 2022, Pediatric blood & cancer.

CD304/neuropilin‐1 is a very useful and dependable marker for the measurable residual disease assessment of B‐cell precursor acute lymphoblastic leukemia

G. Chatterjee, S. Gujral, P. Subramanian, 2020, Cytometry. Part B, Clinical cytometry.

Critical Role of Flow Cytometric Immunophenotyping in the Diagnosis, Subtyping, and Staging of T-Cell/NK-Cell Non-Hodgkin’s Lymphoma in Real-World Practice: A Study of 232 Cases From a Tertiary Cancer Center in India

G. Chatterjee, S. Gujral, P. Subramanian, 2022, Frontiers in Oncology.

Over expression of brain and acute leukemia, cytoplasmic and ETS‐related gene is associated with poor outcome in acute myeloid leukemia

S. Gujral, P. Subramanian, P. Tembhare, 2020 .

Transient abnormal myelopoiesis: A case series and review of the literature

S. Gujral, P. Subramanian, B. Arora, 2017 .

Evaluation of new markers for minimal residual disease monitoring in B‐cell precursor acute lymphoblastic leukemia: CD73 and CD86 are the most relevant new markers to increase the efficacy of MRD 2016; 00B: 000–000

Nisha Ghatwai, G. Chatterjee, S. Gujral, 2018, Cytometry. Part B, Clinical cytometry.

Immunophenotypic shift in the B‐cell precursors from regenerating bone marrow samples: A critical consideration for measurable residual disease assessment in B‐lymphoblastic leukemia

G. Chatterjee, S. Gujral, P. Subramanian, 2020, Cytometry. Part B, Clinical cytometry.

Utility of CD36 as a novel addition to the immunophenotypic signature of RAM‐phenotype acute myeloid leukemia and study of its clinicopathological characteristics

G. Chatterjee, S. Gujral, P. Subramanian, 2020, Cytometry. Part B, Clinical cytometry.

CD19 negative precursor B acute lymphoblastic leukemia (B‐ALL)—Immunophenotypic challenges in diagnosis and monitoring: A study of three cases

S. Gujral, P. Subramanian, P. Tembhare, 2017, Cytometry. Part B, Clinical cytometry.

Evaluation of CD229 as a new alternative plasma cell gating marker in the flow cytometric immunophenotyping of monoclonal gammopathies

G. Chatterjee, S. Gujral, P. Subramanian, 2018, Cytometry. Part B, Clinical cytometry.

Expression of CD304/neuropilin‐1 in adult b‐cell lymphoblastic leukemia/lymphoma and its utility for the measurable residual disease assessment

G. Chatterjee, S. Gujral, P. Subramanian, 2021, International journal of laboratory hematology.

A novel machine-learning-derived genetic score correlates with measurable residual disease and is highly predictive of outcome in acute myeloid leukemia with mutated NPM1

S. Kannan, G. Chatterjee, S. Gujral, 2019, Blood Cancer Journal.

Clinicoepidemiological Profile and Outcome Predicted by Minimal Residual Disease in Children With Mixed-phenotype Acute Leukemia Treated on a Modified MCP-841 Protocol at a Tertiary Cancer Institute in India.

S. Gujral, P. Subramanian, P. Tembhare, 2020, Journal of pediatric hematology/oncology.

'Childhood systemic mastocytosis associated with t (8; 21) (q22; q22) acute myeloid leukemia'

S. Gujral, P. Subramanian, P. Tembhare, 2016, Indian journal of pathology & microbiology.

Applicability of 2008 World Health Organization classification system of hematolymphoid neoplasms: Learning experiences

M. Muckaden, A. Agrawal, V. Rangarajan, 2018, Indian journal of pathology & microbiology.

Characteristics of BCR-ABL kinase domain mutations in chronic myeloid leukemia from India: not just missense mutations but insertions and deletions are also associated with TKI resistance

S. Gujral, P. Subramanian, P. Tembhare, 2016, Leukemia & lymphoma.

Comparison of platelet counts by CellDyn Sapphire (Abbot Diagnostics), LH750 (Beckman Coulter), ReaPanThrombo immunoplatelet method (ReaMetrix), and the international flow reference method, in thrombocytopenic blood samples

S. Talole, S. Gujral, P. Subramanian, 2010, Cytometry. Part B, Clinical cytometry.

BRAFV600E mutation in hairy cell leukemia: A single-center experience

S. Gujral, P. Subramanian, P. Tembhare, 2018, Indian journal of pathology & microbiology.

Utility of Immunophenotypic Measurable Residual Disease in Adult Acute Myeloid Leukemia—Real-World Context

S. Kannan, G. Chatterjee, S. Gujral, 2019, Front. Oncol..

Method for DNA Ploidy Analysis Along with Immunophenotyping for Rare Populations in a Sample using FxCycle Violet

P. Subramanian, P. Tembhare, S. Ghogale, 2017, Current protocols in cytometry.

Cytogenetic study in CML

P. Subramanian, 2012, The Indian journal of medical research.

Mimics and artefacts of measurable residual disease in a highly sensitive multicolour flow cytometry assay for B‐lymphoblastic leukaemia/lymphoma: critical consideration for analysis of measurable residual disease

G. Chatterjee, S. Gujral, P. Subramanian, 2021, British journal of haematology.

Immunophenotypic profile of plasma cell leukemia: a retrospective study in a reference cancer center in India and review of literature.

S. Gujral, P. Subramanian, P. Tembhare, 2011, Indian journal of pathology & microbiology.

Bortezomib in Combination with Cyclophosphamide and G-CSF for Hematopoietic Stem Cell Mobilization in Patients with Multiple Myeloma

S. Kannan, S. Gujral, P. Subramanian, 2018, Blood.

A novel case of intrachromosomal amplification and insertion of RUNX1 on derivative chromosome 2 in pediatric AML.

P. Subramanian, G. Narula, H. Jain, 2021, Cancer genetics.

Long term outcome of a patient with relapsed refractory early thymic precursor acute lymphoblastic leukemia treated with daratumumab.

P. Subramanian, P. Tembhare, A. Bonda, 2021, American Journal of Blood Research.

Copy number gain of JAK2 on marker chromosome in a case of relapsed pediatric B‐ALL

P. Subramanian, P. Tembhare, C. Dhamne, 2022, Pediatric blood & cancer.

Treatment of Pediatric Acute Promyelocytic Leukemia with Retinoic Acid and Arsenic Trioxide along with Chemotherapy.

P. Subramanian, P. Tembhare, S. Banavali, 2023, Indian journal of pediatrics.

Importance of conventional cytogenetics in the identification of ins(19;X)(q13.1;p11.2q28) and t(1;11)(q10;p10), both, novel cytogenetic abnormalities in a pediatric AML case.

P. Subramanian, P. Tembhare, S. Banavali, 2021, Cancer genetics.